Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination

This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID‐19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikema, Shunsuke, Miura, Gen, Shimizu, Daisuke, Baba, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645608/
https://www.ncbi.nlm.nih.gov/pubmed/38028086
http://dx.doi.org/10.1002/ccr3.8181
_version_ 1785147389586178048
author Ikema, Shunsuke
Miura, Gen
Shimizu, Daisuke
Baba, Takayuki
author_facet Ikema, Shunsuke
Miura, Gen
Shimizu, Daisuke
Baba, Takayuki
author_sort Ikema, Shunsuke
collection PubMed
description This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID‐19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no recurrence was observed for 1 year.
format Online
Article
Text
id pubmed-10645608
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106456082023-11-14 Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination Ikema, Shunsuke Miura, Gen Shimizu, Daisuke Baba, Takayuki Clin Case Rep Case Report This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID‐19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no recurrence was observed for 1 year. John Wiley and Sons Inc. 2023-11-14 /pmc/articles/PMC10645608/ /pubmed/38028086 http://dx.doi.org/10.1002/ccr3.8181 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ikema, Shunsuke
Miura, Gen
Shimizu, Daisuke
Baba, Takayuki
Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination
title Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination
title_full Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination
title_fullStr Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination
title_full_unstemmed Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination
title_short Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination
title_sort long‐term follow‐up of a young male who developed acute macular neuroretinopathy following covid‐19 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645608/
https://www.ncbi.nlm.nih.gov/pubmed/38028086
http://dx.doi.org/10.1002/ccr3.8181
work_keys_str_mv AT ikemashunsuke longtermfollowupofayoungmalewhodevelopedacutemacularneuroretinopathyfollowingcovid19vaccination
AT miuragen longtermfollowupofayoungmalewhodevelopedacutemacularneuroretinopathyfollowingcovid19vaccination
AT shimizudaisuke longtermfollowupofayoungmalewhodevelopedacutemacularneuroretinopathyfollowingcovid19vaccination
AT babatakayuki longtermfollowupofayoungmalewhodevelopedacutemacularneuroretinopathyfollowingcovid19vaccination

Ejemplares similares